Preventing Early Renal Loss in Diabetes (PERL) study: A randomized double-blinded trial of allopurinoldrationale, design, and baseline data

Maryam Afkarian, Sarit Polsky, Afshin Parsa, Ronnie Aronson, Maria Luiza Caramori, David Z. Cherney, Jill P. Crandall, Ian H. De Boer, Thomas G. Elliott, Andrzej T. Galecki, Allison B. Goldfine, J. Sonya Haw, Irl B. Hirsch, Amy B. Karger, Ildiko Lingvay, David M. Maahs, Janet B. McGill, Mark E. Molitch, Bruce A. Perkins, Rodica Pop-BusuiMarlon Pragnell, Sylvia E. Rosas, Peter Rossing, Peter Senior, Ronald J. Sigal, Catherine Spino, Katherine R. Tuttle, Guillermo E. Umpierrez, Amisha Wallia, Ruth S. Weinstock, Chunyi Wu, Michael Mauer, Alessandro Doria*, PERL Study Group

*Corresponding author for this work
21 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Preventing Early Renal Loss in Diabetes (PERL) study: A randomized double-blinded trial of allopurinoldrationale, design, and baseline data'. Together they form a unique fingerprint.

Medicine & Life Sciences